These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9883987

  • 1. Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.
    Elizalde PV, Lanari C, Molinolo AA, Guerra FK, Balañá ME, Simian M, Iribarren AM, Charreau EH.
    J Steroid Biochem Mol Biol; 1998 Nov; 67(4):305-17. PubMed ID: 9883987
    [Abstract] [Full Text] [Related]

  • 2. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME, Lupu R, Labriola L, Charreau EH, Elizalde PV.
    Oncogene; 1999 Nov 04; 18(46):6370-9. PubMed ID: 10597237
    [Abstract] [Full Text] [Related]

  • 3. Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.
    Guerra FK, Eijan AM, Puricelli L, Alonso DF, Bal de Kier Joffé E, Kornblihgtt AR, Charreau EH, Elizalde PV.
    Int J Cancer; 1996 Mar 15; 65(6):812-20. PubMed ID: 8631597
    [Abstract] [Full Text] [Related]

  • 4. [Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
    Elizalde PV, Balaña ME, Charreau EH.
    Medicina (B Aires); 1997 Mar 15; 57 Suppl 2():70-4. PubMed ID: 9580484
    [Abstract] [Full Text] [Related]

  • 5. Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.
    Lamb C, Simian M, Molinolo A, Pazos P, Lanari C.
    J Steroid Biochem Mol Biol; 1999 Mar 15; 70(4-6):133-42. PubMed ID: 10622401
    [Abstract] [Full Text] [Related]

  • 6. Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.
    Balañá ME, Labriola L, Salatino M, Movsichoff F, Peters G, Charreau EH, Elizalde PV.
    Oncogene; 2001 Jan 04; 20(1):34-47. PubMed ID: 11244498
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors.
    Viegas MH, Salatino M, Goin M, Peters G, Labriola L, Costa da cunha J, Lanari C, Charreau EH, Elizalde PV.
    Cancer Detect Prev; 1999 Jan 04; 23(5):375-86. PubMed ID: 10468889
    [Abstract] [Full Text] [Related]

  • 8. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
    Dran G, Luthy IA, Molinolo AA, Montecchia F, Charreau EH, Pasqualini CD, Lanari C.
    Breast Cancer Res Treat; 1995 Aug 04; 35(2):173-86. PubMed ID: 7647339
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 10. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C, Lüthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA.
    Cancer Res; 2001 Jan 01; 61(1):293-302. PubMed ID: 11196177
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M, Okawa T, Pan H, Aoki C, Takahashi K, Zue J, Suzuki F, Kinoshita A.
    Endocrinology; 1997 Oct 01; 138(10):4390-400. PubMed ID: 9322955
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice.
    Elizalde PV, Lanari C, Kordon E, Tezón J, Charreau EH.
    Breast Cancer Res Treat; 1990 Jul 01; 16(1):29-39. PubMed ID: 2145045
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells.
    De Leon DD, Wilson DM, Powers M, Rosenfeld RG.
    Growth Factors; 1992 Jul 01; 6(4):327-36. PubMed ID: 1340210
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice.
    Molinolo A, Simian M, Vanzulli S, Pazos P, Lamb C, Montecchia F, Lanari C.
    Cancer Lett; 1998 Apr 10; 126(1):49-57. PubMed ID: 9563648
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the IGF axis components in isolated rat hepatic stellate cells.
    Scharf JG, Knittel T, Dombrowski F, Müller L, Saile B, Braulke T, Hartmann H, Ramadori G.
    Hepatology; 1998 May 10; 27(5):1275-84. PubMed ID: 9581681
    [Abstract] [Full Text] [Related]

  • 20. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K, Höflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, Schwarz HP, Kiess W.
    J Cell Physiol; 1994 Jun 10; 159(3):531-41. PubMed ID: 8188767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.